Cellebrite DI Ltd. authorized a corporate restructuring to create a new U.S. corporation as its ultimate parent company, subject to shareholder and regulatory approval. The company expects the redomiciling to be completed in the first half of 2027 and says the move could support growth in its largest geographic market and among major government customers outside the United States. Chief Executive Officer Shiv Ramji said a U.S. domicile could also improve Cellebrite’s eligibility for major indexes and broaden its investor base. Further details, including those related to an extraordinary general meeting, are expected in future Securities and Exchange Commission filings.